BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 4083860)

  • 1. Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis.
    Perfect JR; Durack DT
    Antimicrob Agents Chemother; 1985 Dec; 28(6):751-5. PubMed ID: 4083860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.
    Louie A; Liu W; Miller DA; Sucke AC; Liu QF; Drusano GL; Mayers M; Miller MH
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2831-40. PubMed ID: 10582868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ornithyl amphotericin methyl ester treatment of experimental candidiasis in rats.
    Galgiani JN; VanWyck DB
    Antimicrob Agents Chemother; 1984 Jul; 26(1):108-9. PubMed ID: 6476814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester.
    Kobayashi GS; Little JR; Medoff G
    Antimicrob Agents Chemother; 1985 Mar; 27(3):302-5. PubMed ID: 3994345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
    Louie A; Kaw P; Banerjee P; Liu W; Chen G; Miller MH
    Antimicrob Agents Chemother; 2001 Feb; 45(2):485-94. PubMed ID: 11158745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B.
    Parmegiani RM; Loebenberg D; Antonacci B; Yarosh-Tomaine T; Scupp R; Wright JJ; Chiu PJ; Miller GH
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1756-60. PubMed ID: 3324961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304.
    Perfect JR; Wright KA; Hobbs MM; Durack DT
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1735-40. PubMed ID: 2556078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice.
    Gadebusch HH; Pansy F; Klepner C; Schwind R
    J Infect Dis; 1976 Nov; 134(5):423-7. PubMed ID: 792355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains.
    Witt MD; Imhoff T; Li C; Bayer AS
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2030-2. PubMed ID: 8239628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-fluorocytosine in the treatment of cryptococcal and candida mycoses.
    Fass RJ; Perkins RL
    Ann Intern Med; 1971 Apr; 74(4):535-9. PubMed ID: 5551162
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of cilofungin (LY121019) for treatment of experimental Candida albicans endocarditis in rabbits.
    Padula A; Chambers HF
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1822-3. PubMed ID: 2686548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of MS-8209, a nonester amphotericin B derivative, in treatment of experimental systemic mycoses.
    Saint-Julien L; Joly V; Seman M; Carbon C; Yeni P
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2722-8. PubMed ID: 1482139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits.
    Chemlal K; Saint-Julien L; Joly V; Farinotti R; Seta N; Yeni P; Carbon C
    Antimicrob Agents Chemother; 1996 Jan; 40(1):263-6. PubMed ID: 8787921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphotericin B lipid complex in the treatment of experimental cryptococcal meningitis and disseminated candidosis.
    Perfect JR; Wright KA
    J Antimicrob Chemother; 1994 Jan; 33(1):73-81. PubMed ID: 8157577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.
    Perfect JR; Savani DV; Durack DT
    Antimicrob Agents Chemother; 1986 Apr; 29(4):579-83. PubMed ID: 3010846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in-vivo activity of an antifungal antibiotic, benanomicin A, in comparison with amphotericin B and fluconazole.
    Ohtsuka K; Watanabe M; Orikasa Y; Inouye S; Uchida K; Yamaguchi H; Kondo S; Takeuchi T
    J Antimicrob Chemother; 1997 Jan; 39(1):71-7. PubMed ID: 9044030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis.
    Jafari HS; Sáez-Llorens X; Severien C; Parras F; Friedland I; Rinderknecht S; Ehrett S; Olsen KD; Abramowsky C; McCracken GH
    Antimicrob Agents Chemother; 1994 Jan; 38(1):83-9. PubMed ID: 7511361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans.
    Victorio GB; Bourdon LMB; Benavides LG; Huerta-Olvera SG; Plascencia A; Villanueva J; Martinez-Lopez E; Hernández-Cañaveral II
    Mem Inst Oswaldo Cruz; 2017 May; 112(5):370-375. PubMed ID: 28443984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal Efficacy of Amphotericin B in Candida Albicans Endocarditis Therapy: Systematic Review.
    Bezerra LS; Silva JAD; Santos-Veloso MAO; Lima SG; Chaves-Markman ÂV; Jucá MB
    Braz J Cardiovasc Surg; 2020 Oct; 35(5):789-796. PubMed ID: 33118745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphotericin B therapy in children; a review of the literature and a case report.
    Cherry JD; Lloyd CA; Quilty JF; Laskowski LF
    J Pediatr; 1969 Dec; 75(6):1063-9. PubMed ID: 4902629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.